Results 41 to 50 of about 96,798 (264)

An analysis of defibrillation and cardiac resynchronization therapy strategies in patients with failing systemic right ventricles [PDF]

, 2007
Includes bibliographical references (leaves 52-56).The expanding application of cardiac resynchronization (CRT) and implantable cardioverter-defibrillator therapy (lCD) to include patients with congenital heart disease requires careful evaluation of ...
Michael, Kevin A
core   +1 more source

Coronary Flow in Hypertrophic Obstructive Cardiomyopathy—Immediate Effects of Alcohol Septal Ablation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
Vojko V. Misevic, Ana N. Golocevac, Kosta S. Krupnikovic, Stefan B. Timcic, Natalija B. Arnautovic, Dragana D. Radoicic, Milan R. Dobric, Aleksandar D. Mandic, Stefan S. Zivkovic, Aleksa D. Obradovic, Vladimir D. Mihajlovic, Natalija R. Odanovic, Ivan S. Ilic   +12 more
wiley   +1 more source

S-ICD oversensing detected by remote monitoring using a new atrial fibrillation diagnostic algorithm

Indian Pacing and Electrophysiology Journal, 2018
A 64-year-old male with a high body mass index, and subcutaneous implantable cardioverter defibrillator, (S-ICD) presented with a remote transmission of inappropriately diagnosed AF episodes, due to oversensing of P and T waves.
Christopher Monkhouse, Andre Jacinto, Pier D. Lambiase   +2 more
doaj   +1 more source

First Case Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator

JACC: Case Reports, 2023
Electromagnetic interference (EMI) between implantable left ventricular assist devices and cardiac implantable electronic devices has been observed. We demonstrated the first case of EMI between a percutaneous ventricular assist device and an implantable
Kosuke Takahari, MD, Takafumi Oka, MD, PhD, Takayuki Sekihara, MD, Kentaro Ozu, MD, Yasuhiro Akazawa, MD, PhD, Daisuke Nakamura, MD, Isamu Mizote, MD, PhD, Tomohito Ohtani, MD, PhD, Shungo Hikoso, MD, PhD, Yasushi Sakata, MD, PhD   +9 more
doaj   +1 more source

Comparison Between the Acurate Neo and the Acurate Neo 2 Transcatheter Heart Valve System: Impact of Midframe Under‐Expansion

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve implantation (TAVI) with the Acurate Neo has been linked to a significant incidence of paravalvular leakage (PVL), addressed by the Acurate Neo 2 incorporating an active sealing skirt. Recent findings suggest that midframe under‐expansion is associated with worse outcomes.
Lisa Crusius, Thaddäus Ast, Stephan Haussig, Jean‐Honoré Steul, Felix J. Woitek, Peter Sick, Tomas Madej, Utz Kappert, Axel Linke, Norman Mangner   +9 more
wiley   +1 more source

A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data an underestimation? [PDF]

, 2015
Implantable cardioverter defibrillator (ICD) implantation carries a significant risk of complications, however published estimates appear inconsistent. We aimed to present a contemporary systematic review using meta-analysis methods of ICD complications ...
Ezzat, VA, Chow, AW, Lee, V, Segal, O, Lambiase, PD, Ahsan, S, Rowland, E, Lowe, MD   +7 more
core  

Percutaneous Left Atrial Appendage Closure Using a PFO Occluder After an Incomplete Surgical Ligation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The case regards a 73‐year‐old male who was referred for consideration of percutaneous left atrial appendage closure. His left atrial appendage was ligated during prior mitral valve surgery, but was noted to be patent on a recent transesophageal echocardiography. An Amulet device was selected based on CT planning.
Zach Rozenbaum, Eric Gnall
wiley   +1 more source

Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy

Archives of Medical Science, 2021
Introduction Implantable cardioverter defibrillators register various types of arrhythmias. Thus they can be exploited to better identify patients with atrial fibrillation episodes and increase the proportion of patients who may benefit from ...
Barbara Dominik, Przemyslaw Mitkowski, Wojciech Zorawski, Ilona Kowalik, Adam Ciesielski   +4 more
doaj   +1 more source

Remote Monitoring of Implantable Cardioverter Defibrillator [PDF]

, 2006
The rate of implantable cardioverter defibrillator (ICD) implantation has gone up as primary and secondary prevention trials have relatively consistently shown significant improvement in mortality and morbidity.
Dwight W. Reynolds, N. Jayaprasad, Johnson Francis, Jayaprasad, N, Francis, Johnson, Reynolds, Dwight W   +5 more
core  

Dental management of a patient fitted with subcutaneous Implantable Cardioverter Defibrillator device and concomitant warfarin treatment

Saudi Dental Journal, 2015
Automated Implantable Cardioverter Defibrillators (AICD), simply known as an Implantable Cardioverter Defibrillator (ICD), has been used in patients for more than 30 years.
Altaf Hussain Shah, Hesham Saleh Khalil, Mohammed Zaheer Kola   +2 more
doaj   +1 more source